Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Feb. 02, 2024	Feb. 03, 2023	Jan. 28, 2022
Cash flows from operating activities:
Net earnings	$ 7,726	$ 6,437	$ 8,442
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	1,923	1,981	1,882
Noncash lease expense	499	530	517
Deferred income taxes	6	(239)	135
Asset impairment and loss on property - net	83	2,118	34
(Gain)/loss on sale of business	(79)	421	0
Share-based payment expense	210	223	230
Changes in operating assets and liabilities:
Merchandise inventory – net	1,637	(2,594)	(1,413)
Other operating assets	182	56	(23)
Accounts payable	(1,820)	(549)	466
Deferred revenue	(170)	(183)	413
Other operating liabilities	(2,057)	388	(570)
Net cash provided by operating activities	8,140	8,589	10,113
Cash flows from investing activities:
Purchases of investments	(1,785)	(1,189)	(3,065)
Proceeds from sale/maturity of investments	1,722	1,174	3,293
Capital expenditures	(1,964)	(1,829)	(1,853)
Proceeds from sale of property and other long-term assets	53	45	113
Proceeds from sale of business	100	491	0
Other – net	(27)	(1)	(134)
Net cash used in investing activities	(1,901)	(1,309)	(1,646)
Cash flows from financing activities:
Net change in commercial paper	(499)	499	0
Net proceeds from issuance of debt	2,983	9,667	4,972
Repayment of debt	(601)	(867)	(2,118)
Proceeds from issuance of common stock under share-based payment plans	141	151	132
Cash dividend payments	(2,531)	(2,370)	(1,984)
Repurchases of common stock	(6,138)	(14,124)	(13,012)
Other – net	(21)	(5)	(6)
Net cash used in financing activities	(6,666)	(7,049)	(12,016)
Effect of exchange rate changes on cash	0	(16)	(8)
Net (decrease)/increase in cash and cash equivalents	(427)	215	(3,557)
Cash and cash equivalents, beginning of year	1,348	1,133	4,690
Cash and cash equivalents, end of year	$ 921	$ 1,348	$ 1,133